Exhibiting at FOOD INGREDIENTS CHINA 2025

Shijiazhuang Huaxu Pharmaceutical Co., Ltd. is a specialized Chinese manufacturer focused on the development and production of pharmaceutical-grade sugar alcohols and specialty carbohydrates. Based in Shijiazhuang, Hebei Province, the company serves a critical role in the supply chain for pharmaceutical excipients, functional food ingredients, and nutraceutical formulations across international markets.

Core Business and Offerings

The company’s operations are centered around polyol and carbohydrate chemistry, particularly the production of high-purity sugar alcohols and rare monosaccharides. Its product range includes:

Sugar Alcohols

• Mannitol: Used extensively as a pharmaceutical excipient and in intravenous therapy.
• Sorbitol: A widely used humectant and sweetener in food, cosmetic, and pharmaceutical applications.
• Lactitol: Applied in laxatives, sugar-free formulations, and as a prebiotic additive.

Monosaccharides

• D-Mannose: Popular in urinary health supplements and diabetic-friendly food products.
• Fructose: Used in functional foods and beverages.
• D-Psicose: A rare sugar gaining attention for its ultra-low caloric profile and anti-hyperglycemic properties.

Disaccharides

• Lactulose: A semi-synthetic sugar used primarily as a laxative and prebiotic agent in the pharmaceutical industry.

These products are manufactured to meet pharmaceutical and food-grade standards, positioning the company as a dual-sector supplier.

Specialization and Unique Strengths

Shijiazhuang Huaxu’s key strength lies in its fermentation and crystallization expertise, which allows it to deliver sugar derivatives with extremely low impurity levels and high batch consistency. The company also specializes in custom molecule development for rare sugars like D-Psicose and D-Mannose, which are in high demand for clinical nutrition and diabetic formulations.

They maintain in-house capabilities for:

• Chromatographic purification
• Vacuum drying and particle sizing
• Analytical HPLC testing for each batch

Financials and Global Reach

While official revenue figures are not publicly available, the company is actively engaged in international trade:

• Based on data from global trade platforms such as ImportYeti and Volza, Shijiazhuang Huaxu has completed over 300 international shipments since 2020.
• Key export destinations include:
  • Germany and Switzerland (for pharmaceutical use)
  • United States and Canada (for nutraceuticals)
  • India and South Korea (for both pharmaceutical and food applications)

These records reflect a growing international customer base and the company’s ability to meet stringent quality specifications in regulated markets.

Target Market

Huaxu Pharmaceutical targets:

• Pharmaceutical formulation companies
• Clinical nutrition manufacturers
• Health food and dietary supplement producers
• Global ingredient distributors focused on rare sugars and sugar alcohols

Their clients include both multinational corporations and regional formulation labs, especially those developing formulations for diabetic, pediatric, and geriatric patient groups.

Capabilities

• GMP-compliant manufacturing facilities
• ISO Class cleanrooms for final packaging
• End-to-end quality control from raw material to finished product
• Batch traceability and technical documentation
• Customization for mesh size, solubility, and flowability

Certifications and Compliance

Shijiazhuang Huaxu ensures regulatory alignment through:

• ISO 9001 for Quality Management
• GMP Compliance for pharmaceutical ingredients
• KOSHER and HALAL Certifications
• Products compliant with USP, BP, EP, and FCC monographs

All exported goods are supported with Certificate of Analysis (CoA), Material Safety Data Sheets (MSDS), and Stability Data, as per client requirements.

Major Achievements

• Pioneered the commercial-scale production of D-Psicose in China with over 98% purity.
• Established long-term export contracts with pharmaceutical companies in Germany and the US.
• Named a Top 10 Specialty Sugar Exporter by a regional trade association in Hebei.
• Developed proprietary crystallization technology reducing impurity levels by 40% compared to industry average.

Shijiazhuang Huaxu Pharmaceutical Co., Ltd. continues to drive innovation in carbohydrate chemistry, offering precision-formulated ingredients that meet the rigorous demands of pharmaceutical and nutraceutical industries worldwide.